Fundraise

IntelliProve raises €2.7M to put its face-scan health check on robots

What's the deal? Belgian healthtech startup IntelliProveDealroom has a profile for this one. Try Dealroom → has raised €2.7 million in seed funding to extend its camera-based health scan from virtual care apps to humanoid robots. Miles AheadDealroom has a profile for this one. Try Dealroom → led the round, with home nursing organisation Wit-Gele Kruis and the imec.istart Fund also taking part.

What's the endgame? The Ghent company's software reads heart rate, heart rate variability, breathing, and blood pressure from a 30-second face scan using a standard camera, no cuff required. Care providers, insurers, and wellbeing platforms in more than 50 countries already build it into their apps. Now it wants the same layer inside robots entering homes and care facilities.

How the scan works: The technique, known as remote photoplethysmography, detects the slight colour change in facial skin with each heartbeat. IntelliProve says its models are validated on more than 6 million data points, and in its own tests 97.6% of heart rate readings fell within five beats per minute of a reference device.

Where the money goes: Roughly a third funds regulatory work, a third research, and a third commercial growth, including robotics deployments, co-chief executive officer Joeri Tulkens told TNW. The company already holds a CE mark as a Class I medical device under the EU Medical Device Regulation and is working towards Class IIa certification.

By the numbers: The raise sits in the top 10% of all seed rounds in Belgium, out of a sample of 1,057. "Our ambition is simple: a health sensing layer that care can rely on, on any camera," Tulkens said.

What could go wrong? IntelliProve says it already works with selected robotics partners but would not name them, leaving the robotics push as early evidence rather than proof of a scaled market. Certification and validation—not just adding software to a phone or robot—remain the key hurdles.

The signal: The round lands as camera-based vital-sign monitoring moves from wellness claims toward regulated clinical use, with rivals PanopticAIDealroom has a profile for this one. Try Dealroom → and Presage TechnologiesDealroom has a profile for this one. Try Dealroom → recently winning US Food and Drug Administration clearances. It also rides growing investment in care and eldercare robotics. The bet is less about size than whether contactless health checks can prove accurate and certified enough for care settings.

Read more: thenextweb.com

Image credit: IntelliProve

More top stories